Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1992-9-22
|
pubmed:abstractText |
We studied the long-term outcome of patients with chronic hepatitis B virus (HBV) infection who responded to interferon (IFN) therapy. Between 1983 and 1988, 120 patients were included in 5 different protocols; 94 patients were treated with IFN and 26 were controls. Loss of serum HBV-DNA was considered a partial response and occurred in 34 of the treated patients and in 10 of the controls. Only the partial-response patients were followed up for 14-64 months (mean 46 months). HBeAg disappeared in 32/34 of the partial-response treated patients and in 9/10 of the controls. During the follow-up period, 6/34 (18%) treated patients and 1/10 controls suffered a reactivation of the disease with reappearance of HBV-DNA. Only 8/34 (23%) treated patients and 1/10 of the controls lost HBsAg; no statistical differences were observed in baseline characteristics between HBsAg-negative patients and patients who remained HBsAg-positive. Of eight HBsAg-negative treated patients, four were serum HBV-DNA-negative upon polymerase chain reaction and thus formed the HBsAg-negative control cases. Although the frequency of HBsAg loss in treated patients is relatively low, the improvement in liver disease obtained from IFN therapy is sustained over a long period.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0168-8278
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
102-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1380526-Adolescent,
pubmed-meshheading:1380526-Adult,
pubmed-meshheading:1380526-Carrier State,
pubmed-meshheading:1380526-DNA, Viral,
pubmed-meshheading:1380526-Female,
pubmed-meshheading:1380526-Follow-Up Studies,
pubmed-meshheading:1380526-Hepatitis B,
pubmed-meshheading:1380526-Hepatitis B Surface Antigens,
pubmed-meshheading:1380526-Hepatitis B e Antigens,
pubmed-meshheading:1380526-Hepatitis B virus,
pubmed-meshheading:1380526-Humans,
pubmed-meshheading:1380526-Interferons,
pubmed-meshheading:1380526-Male,
pubmed-meshheading:1380526-Middle Aged,
pubmed-meshheading:1380526-Polymerase Chain Reaction,
pubmed-meshheading:1380526-Radioimmunoassay,
pubmed-meshheading:1380526-Time Factors
|
pubmed:year |
1992
|
pubmed:articleTitle |
Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy.
|
pubmed:affiliation |
Department of Gastroenterology, Fundación Jiménez Díaz, Madrid, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|